None

BioLineRx receives two U.S. patent allowances for BL-1021 to treat neuropathic pain

BioLineRx, a biopharmaceutical development company, announced today that two Notices of Allowance have been issued by the United States Patent and Trademark Office (USPTO) for BL-1021, an orally avail...

USPTO issues two notices of allowance for BioLineRx neuropathic pain therapy

BioLineRx has received two notices of allowance from USPTO for BL-1021, an orally available small molecule for treating neuropathic pain.

Lipocine Oral Testosterone Replacement Product Cleared by FDA for Phase III Study

Lipocine Inc. (www.lipocine.com) announced today that the Company recently met with the FDA and received guidance and go-ahead for the Company’s pivotal Phase III study f...

BioLineRx Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain

BioLineRx (NASDAQ:BLRX)(TASE:BLRX), a biopharmaceutical development company, announced today that two Notices of Allowance have been issued by the United States Patent and Tradema...

Light from silicon nanocrystal LEDs

(Helmholtz Association of German Research Centres) Silicon nanocrystals have a size of a few nanometers and possess a high luminous potential. Scientists of KIT and the University of Toronto/Canada ha...

LifeSci Advisors Initiates Coverage of Lipocine Inc.

NEW YORK, NY -- (Marketwired) -- 05/07/13 -- LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has...

Comparison of the α-amylase inhibitor-1 from common bean (Phaseolus vulgaris) varieties and transgenic expression in other legumes.

AbstractThe seeds of peas (Pisum sativum) and chickpeas (Cicer arietinum) expressing a gene for α-amylase inhibitor-1 (αAI) from the common bean (Phaseolus vulgaris) are protected from damage by old...

BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on May 12th

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Fina...

Auxins upregulate nif and fix genes.

In a recent publication we analyzed the global effects triggered by IAA overproduction in S. meliloti RD64 under free-living conditions by comparing the gene expression pattern of wild type 1021 with...

Heterologous expression of Anabaena sp. PCC7120 cyanophycin metabolism genes cphA1 and cphB1 in Sinorhizobium (Ensifer) meliloti 1021.

Sinorhizobium meliloti infects leguminous plants resulting in a nitrogen-fixing symbiosis. Free living cells accumulate poly(3-hydroxybutyrate) (PHB) as carbon and energy source under imbalanced growt...

Genetic and Biochemical Characterization of a Pathway for the Degradation of 2-Aminoethylphosphonate in Sinorhizobium meliloti 1021.

A variety of microorganisms have the ability to use phosphonic acids as sole sources of phosphorus. Here, a novel pathway for degradation of 2-aminoethylphosphonate in the bacterium Sinorhizobium meli...

Population genetic polymorphisms of 17 Y-chromosomal STR loci in South Koreans.

Haplotypes and allele frequencies of 17 Y-chromosomal STR loci included in the AmpFlSTR(®) Yfiler(®) system were obtained from a sample of 1021 unrelated individuals living in 6 provinces of South K...

Magnetic resonance imaging susceptibility artifact due to pigmented intraorbital silicone prosthesis.

Magnetic resonance imaging (MRI) findings of two cases with intracranial disease and pigmented intraorbital prosthetics are presented. A brown prosthetic (Case 1) caused a significant magnetic suscept...